Latest news with #PureHealth
Zawya
2 hours ago
- Business
- Zawya
PureHealth delivers strong H1 results, revenue soars to $3.7bln
PureHealth Holding, a leading healthcare group in the Middle East, today (July 31) announced that its revenue for the first six months surged by 9% to AED13.6 billion ($3.7 billion) driven by broad-based growth across both its healthcare and insurance cover verticals. Unveiling its financial results for the six-month period ended June 30, 2025, the Group said its ebitda rose 8% year-on-year to AED2.3 billion in H1, while net profit reached AED1.03 billion, up 2% year-on-year. As part of its continued evolution and transformation of acquired assets, PureHealth is streamlining its operating model built around two core verticals: Care and Cover. This structure brings together all Group businesses under each vertical, with 'Care' encompassing Hospitals, Procurement, Diagnostics, and Technology, while 'Cover' includes the Group's Insurance operations, said the company in a statement. The new model strengthens PureHealth's ability to deliver coordinated, value-driven services by aligning care delivery with insurance offerings to streamlining operations across all levels of the health ecosystem. Furthermore, as PureHealth is the only entity in the MENA region which has both healthcare and insurance services under one umbrella, this new streamlined approach gives more transparency and clarity for investors to understand the vertical performance of the group. Kamal Al Maazmi, Chairman of PureHealth, said: 'PureHealth's strong performance in the first half of 2025 reflects the profound ambition driving our transformation, building a global, future-ready healthcare ecosystem that is both technologically advanced and deeply human. By aligning innovation with national priorities and international partnerships, we are not only expanding access to care, but we are also reshaping how health is delivered, experienced, and sustained.' Group CEO Shaista Asif said: "We delivered solid growth in the first half of 2025 across both our Care and Cover verticals. Our entry into the Property & Casualty segment through Daman strengthens our ability to offer comprehensive, multi-line coverage. We continue to enhance our services through AI-powered solutions that make healthcare more intelligent and efficient." "As we expand globally, our focus remains on synergies, transformation of the assets, and delivering better health outcomes within communities we operate," stated Asif. The Care Vertical was the largest contributor to revenue during the period, accounting for 72% of the Group's top-line at AED 9.8 billion in revenue, up 7% year-on-year in H1 2025. This growth witnessed across several segments, including Hospitals, Diagnostics, and Technology.- TradeArabia News Service Copyright 2025 Al Hilal Publishing and Marketing Group Provided by SyndiGate Media Inc. (
Al Etihad
11 hours ago
- Business
- Al Etihad
PureHealth delivers Dh1.03 billion net profit in H1 2025
31 July 2025 22:30 ABU DHABI (ALETIHAD) PureHealth Holding, the largest healthcare group in the Middle East, posted a net profit of Dh1.03 billion for the first half of 2025, up 2% year-on-year, as both its Healthcare (Care) and Insurance (Cover) verticals delivered strong performance. Revenue for the period rose 9% to Dh13.6 billion, while EBITDA reached Dh2.3 billion, up 8%.The Care vertical remained the key contributor to the group's top line, accounting for 72% of total revenue, or Dh9.8 billion, supported by robust demand across hospitals, diagnostics, and technology. Hospital visits increased notably, with outpatient volumes rising 13% to 4.4 million and inpatient volumes up 7% to 108,000. Growth in the UAE was bolstered by enhanced services and expanded specialist capacity across the SEHA and SSMC networks. In the UK, Circle Health's acquisition of Fairfield Independent Hospital added inpatient capacity and extended its presence in high-demand the diagnostics segment, PureLab saw a 19% rise in testing volumes to 16.9 million, aided by the integration of SSMC's laboratory. Technology Services also posted remarkable growth, with revenue soaring 170% to Dh367 million, driven by the expansion of PureCS and increased user adoption of the Pura app, which surpassed 620,000 Cover vertical contributed Dh3.8 billion in revenue, a 14% increase, while gross written premiums climbed to Dh4.9 billion. The Group's membership base rose by 6%, reflecting solid customer retention and growth into underpenetrated markets.'Our strong performance in the first half of 2025 reflects the profound ambition driving our transformation,' said Kamal Al Maazmi, Chairman of PureHealth. 'By aligning innovation with national priorities and international partnerships, we are reshaping how health is delivered, experienced, and sustained.'Group CEO Shaista Asif said, 'We delivered solid growth across both our Care and Cover verticals. As we expand globally, our focus remains on transformation, synergies, and delivering better health outcomes.' PureHealth ended the period with a healthy balance sheet, repaying Dh1.85 billion in bank debt and maintaining a Net Debt to EBITDA ratio of 1.4x. The Group continues to pursue international expansion, including the acquisition of Hellenic Healthcare Group in Greece and Cyprus, pending EU regulatory approval.
Khaleej Times
12 hours ago
- Business
- Khaleej Times
PureHealth reports Dh13.6 billion in revenue and Dh1.03 billion in net profit for H1
PureHealth Holding, the largest healthcare group in the Middle East, on Thursday announced a 9 per cent year-on-year revenue increase to Dh13.6 billion in H1 2025, driven by broad-based growth across both its healthcare and insurance verticals. Ebitda rose 8 per cent year-on-year to Dh2.3 billion in H1-2025, while net profit reached Dh1.03 billion, up 2 per cent year-on-year. As part of its continued evolution and transformation of acquired assets, PureHealth is streamlining its operating model built around two core verticals: Care and Cover. This structure brings together all Group businesses under each vertical, with 'Care' encompassing Hospitals, Procurement, Diagnostics, and Technology, while 'Cover' includes the Group's Insurance operations. Kamal Al Maazmi, Chairman of PureHealth, said: 'PureHealth's strong performance in the first half of 2025 reflects the profound ambition driving our transformation, building a global, future-ready healthcare ecosystem that is both technologically advanced and deeply human. By aligning innovation with national priorities and international partnerships, we are not only expanding access to care, but we are also reshaping how health is delivered, experienced, and sustained.' Shaista Asif, Group Chief Executive Officer at PureHealth, commented, 'We delivered solid growth in the first half of 2025 across both our Care and Cover verticals. Our entry into the Property & Casualty segment through Daman strengthens our ability to offer comprehensive, multi-line coverage. We continue to enhance our services through AI-powered solutions that make healthcare more intelligent and efficient. As we expand globally, our focus remains on synergies, transformation of the assets, and delivering better health outcomes within communities we operate.' The Care vertical was the largest contributor to revenue during the period, accounting for 72 per cent of the group's top-line at dh9.8 Billion in revenue, up 7 per cent year-on-year in h1 2025. This growth witnessed across several segments, including hospitals, diagnostics, and technology. Performance in UAE and UK was driven by a 13 per cent increase in outpatient volumes to 4.4 million visits, and a 7 per cent rise in inpatient volumes to 108,000 visits across the Hospitals vertical. In the UAE, this growth was supported by expanded service offerings, increased specialist capacity, and growing demand across SEHA and SSMC networks. In the UK, Circle Health saw increased patient volumes and further strengthened its position through the successful bolt on acquisition of Fairfield Independent Hospital in the Merseyside. The acquisition will expand inpatient capacity and available medical staff, which will ultimately support Circle Health's continued growth in high-demand regions. While Procurement revenue decreased 5 per cent year-on-year to Dh2.6 billion in H1 2025, Rafed has continued expansion of its supplier network. Its recent appointed role as the exclusive distributor for the Abu Dhabi government's Unified Purchasing Programme, has since strengthened its position as a central enabler within the Group's healthcare delivery model. PureLab recorded a 19 per cent year-on-year increase in total testing volume, reaching 16.9 million tests. This strong performance was largely fuelled by enhanced contributions from SEHA and the successful integration of the SSMC laboratory into the PureLab network. The Technology Services reported exceptional growth, with revenue increasing 170 per cent year-on-year to Dh367 million in H1-2025. This was driven by the continued expansion of PureCS, which deployed digital infrastructure and clinical technology solutions across the Group's entities. The Pura app surpassed 620,000 users during the period, while the Group's broader technology backbone is enabling predictive analytics, digital patient engagement, and AI-enhanced care delivery. The Cover vertical revenue increased 14 per cent year-on-year to Dh3.8 billion, supported by an 8 per cent rise in Gross Written Premiums (GWP) to Dh4.9 billion in H1-2025. Growth was further fuelled by new business, driven by expansion into underpenetrated segments and geographies. Membership increased 6 per cent year-on-year, reflecting the Group's compelling value proposition and strong customer retention. PureHealth's balance sheet remains strong, with a Net Debt to Ebitda ratio of 1.4x, providing the Group with ample flexibility to pursue future M&A opportunities and invest in strategic organic growth initiatives across its global healthcare platform. PureHealth repaid Dh1.85 billion in bank debt ahead of its 2027 maturity and currently has no bank debt.
Zawya
17 hours ago
- Business
- Zawya
PureHealth delivers strong H1 2025 results with AED 13.6bln in revenue and AED 1.03bln in net profit
Abu Dhabi – PureHealth Holding PJSC ('PureHealth' or 'the Group') (ADX Symbol: PUREHEALTH), the largest healthcare group in the Middle East, today announced its financial results for the six-month period ended 30 June 2025. The Group delivered a 9% year-on-year revenue increase to AED 13.6 billion in H1 2025, driven by broad-based growth across both its Healthcare (Care) and Insurance (Cover) verticals. EBITDA rose 8% year-on-year to AED 2.3 billion in H1-2025, while net profit reached AED 1.03 billion, up 2% year-on-year. As part of its continued evolution and transformation of acquired assets, PureHealth is streamlining its operating model built around two core verticals: Care and Cover. This structure brings together all Group businesses under each vertical, with 'Care' encompassing Hospitals, Procurement, Diagnostics, and Technology, while 'Cover' includes the Group's Insurance operations. The new model strengthens PureHealth's ability to deliver coordinated, value-driven services by aligning care delivery with insurance offerings to streamlining operations across all levels of the health ecosystem. Furthermore, as PureHealth is the only entity in the MENA region which has both healthcare and insurance services under one umbrella, this new streamlined approach gives more transparency and clarity for investors to understand the vertical performance of the group. H.E. Kamal Al Maazmi, Chairman of PureHealth, said: 'PureHealth's strong performance in the first half of 2025 reflects the profound ambition driving our transformation, building a global, future-ready healthcare ecosystem that is both technologically advanced and deeply human. By aligning innovation with national priorities and international partnerships, we are not only expanding access to care, but we are also reshaping how health is delivered, experienced, and sustained.' Shaista Asif, Group Chief Executive Officer at PureHealth, commented, 'We delivered solid growth in the first half of 2025 across both our Care and Cover verticals. Our entry into the Property & Casualty segment through Daman strengthens our ability to offer comprehensive, multi-line coverage. We continue to enhance our services through AI-powered solutions that make healthcare more intelligent and efficient. As we expand globally, our focus remains on synergies, transformation of the assets, and delivering better health outcomes within communities we operate.' Financial & Operational Highlights Across Healthcare (Care) and Insurance (Cover) Verticals: The Care Vertical was the largest contributor to revenue during the period, accounting for 72% of the Group's top-line at AED 9.8 billion in revenue, up 7% year-on-year in H1 2025. This growth witnessed across several segments, including Hospitals, Diagnostics, and Technology. Performance in UAE and UK was driven by a 13% increase in outpatient volumes to 4.4 million visits, and a 7% rise in inpatient volumes to 108,000 visits across the Hospitals vertical. In the UAE, this growth was supported by expanded service offerings, increased specialist capacity, and growing demand across SEHA and SSMC networks. In the UK, Circle Health saw increased patient volumes and further strengthened its position through the successful bolt on acquisition of Fairfield Independent Hospital in the Merseyside. The acquisition will expand inpatient capacity and available medical staff, which will ultimately support Circle Health's continued growth in high-demand regions. While Procurement revenue decreased 5% year-on-year to AED 2.6 billion in H1 2025, Rafed has continued expansion of its supplier network. Its recent appointed role as the exclusive distributor for the Abu Dhabi government's Unified Purchasing Programme, has since strengthened its position as a central enabler within the Group's healthcare delivery model. PureLab recorded a 19% year-on-year increase in total testing volume, reaching 16.9 million tests. This strong performance was largely fuelled by enhanced contributions from SEHA and the successful integration of the SSMC laboratory into the PureLab network. The Technology Services reported exceptional growth, with revenue increasing 170% year-on-year to AED 367 million in H1-2025. This was driven by the continued expansion of PureCS, which deployed digital infrastructure and clinical technology solutions across the Group's entities. The Pura app surpassed 620,000 users during the period, while the Group's broader technology backbone is enabling predictive analytics, digital patient engagement, and AI-enhanced care delivery. The Cover vertical revenue increased 14% year-on-year to AED 3.8 billion, supported by an 8% rise in Gross Written Premiums (GWP) to AED 4.9 billion in H1-2025. Growth was further fuelled by new business, driven by expansion into underpenetrated segments and geographies. Membership increased 6% year-on-year, reflecting the Group's compelling value proposition and strong customer retention. PureHealth's balance sheet remains strong, with a Net Debt to EBITDA ratio of 1.4x, providing the Group with ample flexibility to pursue future M&A opportunities and invest in strategic organic growth initiatives across its global healthcare platform. PureHealth repaid AED 1.85 billion in bank debt ahead of its 2027 maturity and currently has no bank debt. Strategic Developments PureHealth acquired Hellenic Healthcare Group (HHG), the largest private healthcare provider in Greece and Cyprus, strengthening its presence in Europe and expanding its specialised care footprint. Closing of the transaction is subject to EU regulatory approvals. Circle Health Group completed the acquisition of Fairfield Independent Hospital in Merseyside, adding inpatient capacity and expanding Circle's footprint in high-demand regions across the UK. Daman has received approvals and licensing to enter the Property & Casualty insurance segment, marking its evolution into a comprehensive, multi-line insurer. It also launched new insurance offerings targeting underpenetrated segments and continued scaling digital claims and onboarding systems. SEHA, through Sheikh Khalifa Medical City (SKMC), signed a strategic partnership with Cincinnati Children's Hospital, one of the top ranked US children's hospital, to advance paediatric clinical services, research, and training in Abu Dhabi. Rafed was appointed as the exclusive distributor for the Unified Purchasing Programme under the Abu Dhabi government mandate, reinforcing its central position in the national procurement ecosystem. OneHealth introduced TurnKey Solutions and Home Dialysis Project, supporting PureHealth's expansion toward home-based care and specialised treatment pathways. Outlook PureHealth is advancing its organic growth strategy through targeted investments in high-margin, complex medical capabilities, the development of clinical centres of excellence, and operational efficiency enhancements enabled by digital health and AI. In parallel, PureHealth continues to expand its international footprint through focused M&A, including the acquisition of Hellenic Healthcare Group (HHG) in Greece and Cyprus. The Group's expansion strategy is supported by a balanced capital allocation framework, combining reinvestment in core strengths with a commitment to shareholder returns. -Ends- About PureHealth: PureHealth is the largest healthcare group in the Middle East with an ecosystem that challenges lifespans and reimagines health spans. With 110+ hospitals, 316+ clinics, multiple diagnostic centres, health insurance solutions, pharmacies, health tech, procurement, investments and more, its groundbreaking innovations are at the forefront of healthcare as the company is on a mission to unlock time for humankind. By advancing the Science of Longevity, PureHealth is introducing the healthcare of the future from the United Arab Emirates to the rest of the world. PureHealth's network comprises: SEHA – One of the largest healthcare networks of hospitals and clinics in the UAE SEHA CLINICS - Delivering comprehensive community-based healthcare services Daman (The National Insurance Company) – The UAE's leading health insurer The Medical Office – Overseeing Sheikh Khalifa Hospitals and healthcare facilities established under the initiatives of H.H. The President of the UAE Rafed – The UAE's largest healthcare Group Purchasing Organisation PureLab – Managing and operating the largest network of laboratories in the region One Health – A network that provides end-to-end medical solutions to a base of over 300 healthcare service providers The Life Corner – Abu Dhabi's first holistic pharmacy, serving the health and wellness establishment Ardent Health Services – The fourth largest privately held acute care hospital operator in the US Circle Health Group – The largest independent operators of hospitals in the UK Hellenic Healthcare Group (HHG) - the largest private healthcare provider in Greece and Cyprus PureCS - A leading cloud and technology services provider, specialising in IT management and consulting solutions, cybersecurity, cloud services and AI information systems Sheikh Shakhbout Medical City (SSMC) – The UAE's largest healthcare complex, delivering integrated complex care To learn more, please visit
The National
21-07-2025
- Health
- The National
Abu Dhabi vaccine hub opens in 'logistics milestone' for capital
Operations have begun at an Abu Dhabi vaccine distribution hub primed to deliver millions of doses each year as part of a mission to improve access to health care across the region. The logistics centre, developed by authorities in the capital in partnership with pharmaceutical giant GlaxoSmithKline, has been hailed as a strategic milestone for the emirate. The facility, based at Khalifa Economic Zones Abu Dhabi (Kezad) and operated by Rafed, a subsidiary of PureHealth, is now up and running after receiving its first shipment. It will manage a portfolio of more than 20 vaccines for both adults and children to support efforts to boost immunisation rates and limit the spread of a number of diseases. It features advanced cold-chain and smart distribution technology to preserve vaccines in temperature-controlled environments while being stored and when distributed to other parts of the world. The hub is connected to Etihad Cargo's PharmaLife network, which links Abu Dhabi to more than 100 international destinations and offers time-sensitive, temperature-controlled freight services tailored for pharmaceutical products. 'The operational launch of Abu Dhabi's regional vaccine hub signals our readiness to serve the region with speed, precision, and reliability,' said Dr Noura Khamis Al Ghaithi, Undersecretary of Abu Dhabi's Department of Health. 'More than a logistics milestone, this reflects our long-term vision to position Abu Dhabi as a trusted partner in global health where innovation and resilience translate into timely access and measurable public health impact. 'Through this hub, we are making vaccines more accessible to communities across borders and strengthening the UAE's leadership in preventive, future-ready healthcare.' The hub has been developed under a major global partnership also including Abu Dhabi Investment Office Abu Dhabi Ports Group and Etihad Cargo. Boyd Chongphaisal, vice president and general manager for GSK Gulf, spoke of the significance of the launch of the drug manufacturer's first distribution centre in the Middle East and its fourth in the world. 'The launch of our vaccine distribution hub in Abu Dhabi represents a shared commitment to health security, innovation, and access,' he said. 'Through our strategic partnership with DoH and local stakeholders, we are combining scientific excellence with operational strength to ensure timely, efficient delivery of vaccines across the region.' The partnership between Abu Dhabi and GSK builds on firm foundation developed during the Covid-19 pandemic. In June 2021, Abu Dhabi became the first city to receive Sotrovimab, a GSK-developed drug that eased the symptoms of the most critically ill Covid patients. More than 23,000 people benefited from the drug, and the partnership opened new doors for research collaboration. The UAE cemented its status as a key global player in healthcare logistics during the pandemic, as governments sought to secure swift and efficient methods to deliver essential vaccines. Abu Dhabi's Hope Consortium oversaw a 19,000-square-metre cold and ultra-cold storage facility in Khalifa Industrial Zone Abu Dhabi, which housed tens of millions of Covid-19 vaccines being delivered around the world.
